Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients.
about
Mycobacterium haemophilum osteomyelitis: case report and review of the literature.Emergence of a unique group of necrotizing mycobacterial diseases.Pulmonary nodule due to Mycobacterium haemophilum in an immunocompetent host.Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy.Mycobacterium haemophilum infections in heart transplant recipients: case report and review of the literature.Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infectionsEpidemiology of infection by nontuberculous mycobacteriaMycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.Intracellular growth and cytotoxicity of Mycobacterium haemophilum in a human epithelial cell line (Hec-1-B).Direct identification of Mycobacterium haemophilum in skin lesions of immunocompromised patients by PCR-restriction endonuclease analysis.Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients.Therapy of HIV infection.Nontuberculous mycobacterial osteomyelitis.Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum.Mycobacterium haemophilum bone and joint infection in HIV/AIDS: case report and literature review.Nontuberculous mycobacteria infections in immunosuppressed hosts.Lesser known mycobacteria.Treatment of Mycobacterium haemophilum infection in a murine model with clarithromycin, rifabutin, and ciprofloxacin.Mycobacterium haemophilum: an emerging pathogen.Mycobacterium haemophilum infection in an elderly patient.Epidemiological and clinical aspects of mycobacterial infections.Central nervous system infection due to Mycobacterium haemophilum in a patient with acquired immunodeficiency syndrome.Atypical focal osteomyelitis as initial manifestation of AIDS.Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009.Late-onset postoperative Mycobacterium haemophilum endophthalmitis masquerading as inflammatory uveitis: a case report.Mycobacterium haemophilum in immunocompromised patients.First case of Mycobacterium haemophilum infection in an AIDS patient in Italy**
P2860
Q33239515-0FEBCDBB-DF90-4CD0-A0F5-FE60BDADBB4CQ33643091-2D100561-7B23-4090-8459-7E369B7D0CE1Q33745482-65BF41C5-B90C-4E33-AF16-CBB1959C8023Q33959459-79FB6714-E658-448E-A67A-148D4B3ED7E4Q34746830-1A8C8C19-38CD-4537-931A-2B5182D72543Q35361550-F70265D4-9D36-4EC5-B463-06E4F05CB196Q35370226-6460665C-6C90-4E8A-8AF4-C05EBDC09367Q35371930-EA5511CA-8072-41ED-AE15-0BC74EC61663Q35463776-205BE39F-FFAC-4905-AAFC-EDC56D6422A9Q35718053-C05E0FB7-8B6F-405B-A4E9-B3576518926FQ35779935-26C83574-0AF5-44FC-8A53-5ADB22D087EDQ35967419-60345D24-01D8-4293-B0BC-344BFE3184AEQ36465965-997C313B-6D02-4D42-B2C0-E11CC8C5511DQ36723884-B07EE9A2-1900-4584-B517-070154D12995Q38313910-57A19ECC-1A2A-4C5A-823D-1B2FA7431C25Q38353491-452FA68A-1D25-42E0-82EB-12C255043C93Q39652764-5CB83B0C-45E5-4603-8C03-34A8EA77C28BQ39780641-D8383421-75B0-4B9D-9FBD-AC0FFFE5AC37Q40494926-C1441077-B89C-40DE-A6D9-5524933AE2ECQ40643473-C1FF65EB-5D73-448F-B3E5-CD2FFB4E6B17Q40659190-50DD2C26-1905-4C8C-A89B-63CF31750CBEQ42214714-0D2C2A50-6363-4C9B-BB0B-D664B2633378Q42352012-9F61F3BE-EDB0-461F-BCDA-9E1313FA061EQ42553069-1658013D-95FB-4C81-BF15-B41287BDB490Q49200787-899C4DC6-6BC0-4CFD-948C-928A4DB88E0FQ54002956-C406A533-815B-4347-BD4A-C29ADF1B6E2EQ57564039-B7EB5017-6F3A-452A-8BF2-026E52E7B00E
P2860
Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Clinical and epidemiologic cha ...... in immunocompromised patients.
@en
type
label
Clinical and epidemiologic cha ...... in immunocompromised patients.
@en
prefLabel
Clinical and epidemiologic cha ...... in immunocompromised patients.
@en
P2093
P1476
Clinical and epidemiologic cha ...... in immunocompromised patients.
@en
P2093
Armstrong D
Jernigan DB
Kilburn JO
LaBombardi V
Ostroff SM
Schneider N
P304
P356
10.7326/0003-4819-120-2-199401150-00004
P407
P577
1994-01-01T00:00:00Z